Type 2 diabetes-induced overactivation of P300 contributes to skeletal muscle atrophy by inhibiting autophagic flux
Zhen Fan,Jing Wu,Qiu-Nan Chen,An-Kang Lyu,Jin-Liang Chen,Yue Sun,Qiong Lyu,Yu-Xing Zhao,Ai Guo,Zhi-Yin Liao,Yun-Fei Yang,Shi-Yu Zhu,Xu-Shun Jiang,Bo Chen,Qian Xiao,Qiu-nan Chen,An-kang Lyu,Jin-liang Chen,Yu-xing Zhao,Zhi-yin Liao,Yun-fei Yang,Shi-yu Zhu,Xu-shun Jiang
DOI: https://doi.org/10.1016/j.lfs.2020.118243
IF: 6.78
2020-10-01
Life Sciences
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>Although autophagy impairment is a well-established cause of muscle atrophy and P300 has recently been identified as an important regulator of autophagy, the effects of P300 on autophagy and muscle atrophy in type 2 diabetes (T2D) remain unexplored. We aimed at characterizing the role of P300 in diabetic muscle and its underlying mechanism.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Main methods</h3><p>Protein levels of phosphorylated P300, total P300, acetylated histone H3, LC3, p62 and myosin heavy chain, and mRNA levels of Atrogin-1 and MuRF1 were analyzed in palmitic acid (PA)-treated myotubes and <em>db</em>/<em>db</em> mice. Autophagic flux was assessed using transmission electron microscopy, immunofluorescence and mRFP-GFP-LC3 lentivirus transfection in cells. Muscle weight, blood glucose and grip strength were measured in mice. Hematoxylin and eosin (H&E) staining was performed to determine changes in muscle fiber size. To investigate the effects of P300 on autophagy and myofiber remodeling, a P300 specific inhibitor, c646, was utilized. 3-Methyladenine (3-MA) was utilized to inhibit autophagosomes formation, and chloroquine (CQ) was used to block autophagic flux.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Key findings</h3><p>Phosphorylation of P300 in response to PA enhanced its activity and subsequently suppressed autophagic flux, leading to atrophy-related morphological and molecular changes in myotubes. Inhibition of P300 reestablished autophagic flux and ameliorated PA-induced myotubes atrophy. However, this effect was largely abolished by co-treatment with the autophagy inhibitor CQ. In vivo results demonstrated that inhibition of P300 partially rescued muscle wasting in <em>db</em>/<em>db</em> mice, accompanied with autophagy reactivation.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Significance</h3><p>The findings revealed that T2D-induced overactivation of P300 contributes to muscle atrophy by blocking autophagic flux.</p>
pharmacology & pharmacy,medicine, research & experimental